Exodus Point Capital Management, LP Delcath Systems, Inc. Put Options Transaction History
Exodus Point Capital Management, LP
- $10.1 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DCTH
# of Institutions
104Shares Held
12.1MCall Options Held
79KPut Options Held
53.3K-
Vanguard Group Inc Valley Forge, PA1.39MShares$23.8 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY813KShares$13.9 Million0.26% of portfolio
-
Vivo Capital, LLC Palo Alto, CA750KShares$12.8 Million2.59% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA557KShares$9.53 Million0.0% of portfolio
-
Gilder Gagnon Howe & CO LLC New York, NY539KShares$9.21 Million0.1% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $147M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...